bisbenzimidazole has been researched along with Leukemia P388 in 1 studies
Bisbenzimidazole: A benzimidazole antifilarial agent; it is fluorescent when it binds to certain nucleotides in DNA, thus providing a tool for the study of DNA replication; it also interferes with mitosis.
Leukemia P388: An experimental lymphocytic leukemia originally induced in DBA/2 mice by painting with methylcholanthrene.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gravatt, GL | 1 |
| Baguley, BC | 1 |
| Wilson, WR | 1 |
| Denny, WA | 1 |
1 other study available for bisbenzimidazole and Leukemia P388
| Article | Year |
|---|---|
DNA-directed alkylating agents. 6. Synthesis and antitumor activity of DNA minor groove-targeted aniline mustard analogues of pibenzimol (Hoechst 33258)
Topics: Alkylating Agents; Animals; Antineoplastic Agents; Binding Sites; Bisbenzimidazole; Cell Survival; C | 1994 |